M

Minhang Xin

Zhejiang University

ORCID: 0000-0002-5827-9580

Publishes on PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research, Quinazolinone synthesis and applications. 81 papers and 2.3k citations.

PubIndex Score18Top 82% · seniorHow it's scored

81Publications

2.3kTotal Citations

First publication: 2009First senior author: 2009

PI3K/AKT/mTOR signaling in cancer Chronic Lymphocytic Leukemia Research Quinazolinone synthesis and applications Hedgehog Signaling Pathway Studies Protein Degradation and Inhibitors

Top publicationsby citations

Small molecule selenium-containing compounds: Recent development and therapeutic applications

Hongyan Chuai, Minhang Xin, San‐Qi Zhang et al.|European Journal of Medicinal Chemistry|2021

Cited by 233

Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y

Chengyuan Liang, Juan Xia, Danni Tian et al.|European Journal of Medicinal Chemistry|2019

Cited by 192

The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review

Chengyuan Liang, Suresh Thareja, Danni Tian et al.|European Journal of Medicinal Chemistry|2018

Cited by 168

Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)

Hao Zhang, San‐Qi Zhang, Hongyi Zhao et al.|European Journal of Medicinal Chemistry|2020

Cited by 120

Strategies to target the Hedgehog signaling pathway for cancer therapy

Minhang Xin, Binghe Wang, Xingyue Ji et al.|Medicinal Research Reviews|2018

Cited by 108